To establish the killing mechanism of mAb2, we transplanted MLL-AF9/Flt3ITD/+ AML into immunocompromised mice (NSG) which lack natural killer (NK) cells to participate in an Fc-mediated ADCC and also have an impaired complement system. This evidence concerns the gene MLLT3 and acute myeloid leukemia.